Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

FDA on Risk-Benefit Analysis for Recalls

Hyman, William A. ScD

doi: 10.1097/01.BMSAS.0000490365.22780.c8

Dr. Hyman is Professor Emeritus, Department of Biomedical Engineering, Texas A&M University, College Station, Texas; E-mail:

Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.